Informed consent in cardiac resynchronization therapy what should be said

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 5, 2011, Pages 573-577

  Kramer, Daniel B ^a   Brock, Dan W ^b   Tedrow, Usha B ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Defibrillators implantable; Ethics; Heart failure; Patient centered care

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; DECISION SUPPORT SYSTEM; DEFIBRILLATOR; DISEASE COURSE; HEALTH CARE COST; HEART FAILURE; HUMAN; INFORMED CONSENT; LONGEVITY; MEDICAL INFORMATION; MORTALITY; PATIENT AUTONOMY; PATIENT DECISION MAKING; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUDDEN DEATH; UNCERTAINTY;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CODES OF ETHICS; DEATH, SUDDEN; DECISION MAKING; DISEASE PROGRESSION; HEART FAILURE; HUMANS; INDIVIDUALIZED MEDICINE; INFORMED CONSENT; PERSONAL AUTONOMY; QUALITY OF LIFE;

EID: 80054730393     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.111.961680     Document Type: Review

References (41)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346: 1845-1853 (Pubitemid 34603028)
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350: 2140-2150
3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549 (Pubitemid 40517094)
4. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338
5. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834-1843
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883 (Pubitemid 34984635)
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp- Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237 (Pubitemid 40110811)
8. Daubert JC, Leclercq C, Mabo P. There is plenty of room for cardiac resynchronization therapy devices without back-up defibrillators in the electrical treatment of heart failure. J Am Coll Cardiol. 2005;46: 2204-2207 (Pubitemid 41785486)
9. Beauchamp TL, Childress JF. Principles of Biomedical Ethics, 4th ed. New York, NY: Oxford University Press; 1994:120-169
10. Dworkin G. The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press; 1988:3-84
11. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267:2221-2226
12. Brock DW. Facts and values in the physician/patient relationship. In: Veatch R, Pelligrino E, Langan J, eds. Ethics, Trust, and the Professions: Philosophical and Cultural Aspects. Washington, DC: Georgetown University Press; 1991
13. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007
14. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J; Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-717 (Pubitemid 29407370)
15. Teuteberg JJ, Lewis EF, Nohria A, Tsang SW, Fang JC, Givertz MM, Jarcho JA, Mudge GH, Baughman KL, Stevenson LW. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail. 2006;12:47-53 (Pubitemid 43267751)
16. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443
17. Stevenson WG, Stevenson LW. Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol. 2001;12:112-114 (Pubitemid 32099493)
18. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024 (Pubitemid 32824149)
19. McCullough PA, Abraham WT. Does quality of life evidence assist in the selection of patients for resynchronization therapy? Card Electrophysiol Rev. 2003;7:71-76 (Pubitemid 36758056)
20. Boehmer JP. CRT only or CRT plus ICD? Eur Heart J. 2004;6:D83-D87 (Pubitemid 38993436)
21. Carroll DL, Hamilton GA. Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart Lung. 2005; 34:169-178 (Pubitemid 40704565)
22. Sears SF Jr., Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;87:488-493 (Pubitemid 34454597)
23. Kramer DB, Kesselheim AS, Brock DW, Maisel WH. The ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: A quantitative assessment. Heart Rhythm. 2010;7: 1537-1542
24. Mueller PS, Jenkins SM, Bramstedt KA, Hayes DL. Deactivating implanted cardiac devices in terminally ill patients: Practices and attitudes. Pacing Clin Electrophysiol. 2008;31:560-568 (Pubitemid 351595284)
25. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R; American College of Cardiology, American Geriatrics Society, American Academy of Hospice and Palliative Medicine, American Heart Association, European Heart Rhythm Association, Hospice and Palliative Nurses Association. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDS) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7:1008-1026
26. Berger JT. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med. 2005;142:631-634 (Pubitemid 40529960)
27. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, Pe E, Bradley EH, Morrison RS. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2008:23(suppl 1):7-12 (Pubitemid 350295388)
28. Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, Cannom D, Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123:1061-1072
29. Haines DE, Wang Y, Curtis J. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation. 2011;123:2069-2076
30. Tedrow UB, Kramer DB, Stevenson LW, Stevenson WG, Baughman KL, Epstein LM, Lewis EF. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy. Am J Cardiol. 2006;97:1737-1740 (Pubitemid 43817860)
31. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835-838 (Pubitemid 39601176)
32. Berger JT, Gorski M, Cohen T. Advance health planning and treatment preferences among recipients of implantable cardioverter defibrillators: An exploratory study. J Clin Ethics. 2006;17:72-78 (Pubitemid 43643945)
33. Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011;107:1071-1075
34. Lewis WR, Luebke DL, Johnson NJ, Harrington MD, Costantini O, Aulisio MP. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119:892-896 (Pubitemid 44415609)
35. Agard A, Lofmark R, Edvardsson N, Ekman I. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: Prescription rather than participation. J Med Ethics. 2007;33:514-518
36. Goldstein NE, Back AL, Morrison RS. Titrating guidance: A model to guide physicians in assisting patients and family members who are facing complex decisions. Arch Intern Med. 2008;168:1733-1739
37. Arnold SV, Decker C, Ahmad H, Olabiyi O, Mundluru S, Reid KJ, Soto GE, Gansert S, Spertus JA. Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making. Circ Cardiovasc Qual Outcomes. 2008;1:21-28
38. Goldstein N, Bradley E, Zeidman J, Mehta D, Morrison RS. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: Results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009;54:371-373
39. Stevenson LW. Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: Are there enough bangs for the bucks? Circulation. 2006;114:101-103 (Pubitemid 44420740)
40. Reynolds CR, Jessup M. Translating the benefits of cardiac resynchronization therapy widely and wisely: Challenges remain. Ann Intern Med. 2011;154:436-438
41. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, Dodson GC, O'Connor CM, Felker GM. Discordance between patientpredicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008;299:2533-2542. (Pubitemid 351787209)